Clinical Trials
4 trialsParkinson Disease 4, Autosomal Dominant Lewy Body × 130-nm albumin-bound paclitaxel × 90 days × Clear all
NCT06841354 2026-05-29
TroFuse-011
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT06312176 2026-05-22
MK-2870-010
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT05017012 2026-03-27
MK-3475A-C18
Merck Sharp & Dohme LLC
Phase 1 Active not recruiting
NCT04895358 2026-03-11
KEYNOTE-B49
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting